Market Overview

Benzinga's Top Pre-Market Gainers

Related LRN
Lost Money On K12 Shares In Late 2013? Wait Until You See What Management Kept From You...It's Not Pretty
K12 Inc. is Expanding in Midst of Headwinds and Changing Dynamics
K12's (LRN) CEO Nate Davis on Q2 2015 Results - Earnings Call Transcript (Seeking Alpha)
Related VICL
US Stock Futures Slip; JPMorgan Earnings In Focus
US Stock Futures Edge Higher Ahead Of Retail Sales, Jobless Claims Data
Vical Up on Deal with AnGes to Develop Ebola Treatment - Analyst Blog (Zacks)

K12 (NYSE: LRN) soared 13.66% to $24.30 in the pre-market trading. K12 reported a better-than-expected fourth-quarter profit.

Vical (NASDAQ: VICL) surged 9.28% to $4.12 in the pre-market session. Vical announced today a worldwide, nonexclusive license to Bristol-Myers Squibb Company (NYSE: BMY).

Cliffs Natural Resources (NYSE: CLF) added 2.41% to $41.60 in the pre-market session. Cliffs Natural Resources' PEG ratio is 1.09.

Arena Pharmaceuticals (NASDAQ: ARNA) moved up 1.79% to $8.51 in the pre-market session. Arena Pharmaceuticals shares have surged 464.87% over the past 52 weeks, while the S&P 500 index has gained 20.85% in the same period.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (ARNA + BMY)

Around the Web, We're Loving...

Get Benzinga's Newsletters